GFAP and Alzheimer disease: We further performed immunohistochemistry to confirm the astrocytic localization of SIRT2 and found significant elevation of SIRT2 intensity in the astrocytes (GFAP-positive area) of the hippocampal CA1, CA2, CA3, CA4, and DG in AD patients (Fig. 7 B, D and E).